Lectures (Video)
- 1. What Is Biomedical Engineering?
- 2. What Is Biomedical Engineering? (cont.)
- 3. Genetic Engineering
- 4. Genetic Engineering (cont.)
- 5. Cell Culture Engineering
- 6. Cell Culture Engineering (cont.)
- 7. Cell Communication and Immunology
- 8. Cell Communication and Immunology (cont.)
- 9. Biomolecular Engineering: Engineering of Immunity
- 10. Biomolecular Engineering: Engineering of Immunity (cont.)
- 11. Biomolecular Engineering: General Concepts
- 12. Biomolecular Engineering: General Concepts (cont.)
- 13. Cardiovascular Physiology
- 14. Cardiovascular Physiology (cont.)
- 15. Cardiovascular Physiology (cont.)
- 16. Renal Physiology
- 17. Renal Physiology (cont.)
- 18. Biomechanics and Orthopedics
- 19. Biomechanics and Orthopedics (cont.)
- 20. Bioimaging
- 21. Bioimaging (cont.)
- 22. Tissue Engineering
- 23. Tissue Engineering (cont.)
- 24. Biomedical Engineers and Cancer
- 25. Biomedical Engineers and Artificial Organs
Frontiers of Biomedical Engineering - Lecture 10
|
Get the Flash Player to view video.
Lecture 10 - Biomolecular Engineering: Engineering of Immunity (cont.)
Professor Saltzman continues his presentation on the topic of vaccine. First, Professor Saltzman describes the host immune response to pathogen recognition, in terms of immunoglobulin release, T-cell activation, and memory cell production. The production, distribution, and challenges involved in making of the Salk polio vaccine and the modern, oral polio vaccine are discussed. Professor Saltzman then talks about the range of bioengineering approaches that can be used to produce vaccine: attenuated, subunit, and DNA-based. Finally, a life-intervention cost analysis (cost of technology per human life saved) for vaccine was compared to other policies to further emphasize the impact of vaccine on improving public health worldwide.
Prof. W. Mark Saltzman
BENG 100 Frontiers of Biomedical Engineering, Spring 2008 (Yale University: Open Yale) http://oyc.yale.edu Date accessed: 2009-01-06 License: Creative Commons BY-NC-SA |


